Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α)

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a pivotal transcriptional coactivator that serves as the master regulator of mitochondrial biogenesis and cellular energy homeostasis. It does not bind DNA directly but instead docks onto various transcription factors, such as nuclear respiratory factors (NRFs), peroxisome proliferator-activated receptors (PPARs), and estrogen-related receptors (ERRs), to enhance the expression of genes involved in oxidative metabolism. PGC-1α plays a critical role in adaptive thermogenesis in brown adipose tissue, fatty acid oxidation in the heart, and gluconeogenesis in the liver. Dysregulation of PGC-1α is linked to a wide array of metabolic and age-related conditions, including type 2 diabetes, obesity, and neurodegenerative disorders like Parkinson's and Huntington's disease, where mitochondrial failure is a key feature. While traditionally considered 'undruggable' due to the absence of a classic ligand-binding pocket, therapeutic strategies focus on indirect modulation through upstream activators like AMPK (e.g., metformin) and SIRT1 (e.g., resveratrol) or the development of small-molecule modulators like ZLN005 and TQS-168. Its therapeutic window is narrow, as chronic over-expression in certain tissues like the heart can paradoxically lead to dilated cardiomyopathy.

Other names

PPARGC1APPARGC1PGC1PGC1APGC-1PGC-1 alphaLEM6PGC-1v

Transcriptional coactivation of nuclear receptors and respiratory factors to coordinate the induction of mitochondrial and metabolic gene programs.